MTOR and neuroendocrine carcinoma: The hypervascularization of tumors, coupled with the frequent overexpression of growth factors and constitutive overactivation of the PI3K-Akt-mTOR signaling pathway in neuroendocrine carcinomas, provides a rationale for exploring new molecularly targeted therapeutic approaches (21–23).